Twenty-four soybean genotypes collected from different regions and origin were evaluated for their quality performance to explore their nutritional and medicinal values. The proximate compositions showed considerable variations among soybean genotypes. The USA genotypes recorded the highest values for protein (43.1 g/100 g), total fat (23.61 g/100 g), phenolic content and flavonoids (1.77 and 2.13 mg/g). Using GC-MS analyses of methanolic extracts, a total of 88 compounds were identified in the genotypes and were classified to: 19 heterocyclic compounds, 13 compounds for ketones and esters, 9 for phenolic compound, 7 compounds for carboxylic acids and sugar moiety, 5 compounds for aldehydes and alcohols, 4 ether compounds, 3 amide, 2 alkanes and one alkene and one fatty acid ester. Indonesian genotypes recorded the highest number of phenolic and the Australian genotype A-1 had the maximum number of esters. Genotypes showed high levels of proximate compositions and pharmaceutical components, offering potential candidates for improving those traits in adapted genotypes through breeding program, as well as serving as a good source of mass production of pharmaceutical and medicinal components either through classical or in vitro production. Furthermore, platform was set for isolating and understanding the characteristics of each compound for it pharmacological properties.
Part of the book: Phytochemicals